Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy

O Gordeeva - Seminars in cancer biology, 2018 - Elsevier
Cancer-testis antigens (CTAs) are considered as unique and promising cancer biomarkers
and targets for cancer therapy. CTAs are multifunctional protein group with specific …

Cancer/testis antigens: from serology to mRNA cancer vaccine

C Fan, H Qu, X Wang, N Sobhani, L Wang, S Liu… - Seminars in cancer …, 2021 - Elsevier
Cancer/testis antigens (CTAs) are a group of tumor antigens expressed in numerous cancer
tissues, as well as in the testis and placental tissues. There are over 200 CTAs supported by …

Resveratrol induces AMPK and mTOR signaling inhibition-mediated autophagy and apoptosis in multiple myeloma cells

R Ma, D Yu, Y Peng, H Yi, Y Wang… - Acta Biochimica et …, 2021 - academic.oup.com
Resveratrol, a natural compound extracted from the skins of grapes, berries, or other fruits,
has been shown to have anti-tumor effects against multiple myeloma (MM) via promoting …

[HTML][HTML] The expression, modulation and use of cancer-testis antigens as potential biomarkers for cancer immunotherapy

XF Li, P Ren, WZ Shen, X Jin… - American Journal of …, 2020 - ncbi.nlm.nih.gov
Cancer-testis antigens (CTA) are tumor antigens, present in the germ cells of testes, ovaries
and trophoblasts, which undergo deregulated expression in the tumor and malignant cells …

Integration of IgA and IgG autoantigens improves performance of biomarker panels for early diagnosis of lung cancer

J Pan, L Yu, Q Wu, X Lin, S Liu, S Hu, C Rosa… - Molecular & Cellular …, 2020 - ASBMB
Lung cancer (LC) remains the leading cause of mortality from malignant tumors worldwide.
In our previous study, we surveyed both IgG and IgM-bound serological biomarkers and …

RETRACTED: Study on Attenuating Angiogenesis and Epithelial–Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating …

S Jiang, X Liu, D Li, M Yan, C Ju… - Technology in Cancer …, 2018 - journals.sagepub.com
Objective: To investigate the role of MAGE family member C2 in angiogenesis and epithelial–
mesenchymal transition of non-small cell lung carcinoma. Methods: The Cancer Genome …

Generation of TRIM28 Knockout K562 Cells by CRISPR/Cas9 Genome Editing and Characterization of TRIM28-Regulated Gene Expression in Cell Proliferation and …

YJ Chang, Z Kang, J Bei, SJ Chou, MYJ Lu… - International Journal of …, 2022 - mdpi.com
TRIM28 is a scaffold protein that interacts with DNA-binding proteins and recruits
corepressor complexes to cause gene silencing. TRIM28 contributes to physiological …

Peptides and combination of peptides for use in immunotherapy against various cancers

M Andrea, T Weinschenk, S Colette, O Schoor… - US Patent …, 2019 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …

[HTML][HTML] Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer

A Naik, B Lattab, H Qasem, J Decock - Molecular Therapy Oncology, 2024 - cell.com
Cancer care has witnessed remarkable progress in recent decades, with a wide array of
targeted therapies and immune-based interventions being added to the traditional treatment …

Peptides and combination of peptides for use in immunotherapy against various cancers

M Andrea, T Weinschenk, S Colette, O Schoor… - US Patent …, 2019 - Google Patents
2016-12-30 Assigned to IMMATICS BIOTECHNOLOGIES GMBH reassignment IMMATICS
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …